82 FR 57761 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 234 (December 7, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 234 (December 7, 2017)
| Page Range | 57761-57761 | |
| FR Document | 2017-26324 |
[Federal Register Volume 82, Number 234 (Thursday, December 7, 2017)] [Notices] [Page 57761] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-26324] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01). Date: January 9, 2018. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Jay R. Radke, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3G11B, National Institutes of Health, NIAID, 5601 Fishers Lane MSC- 9823, Bethesda, MD 20892-9823, (240) 669-5046, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 1, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-26324 Filed 12-6-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 234 / Thursday, December 7, 2017 / Notices 57761
to conduct research relating to foods survey will also be updated to explore to complete the survey. The survey will
and to conduct educational and public emerging consumer food safety topics also include an oversample of Hispanics
information programs relating to the and expand understanding of previously and Blacks to ensure a minimum of 400
safety of the nation’s food supply. The asked topics. each. Additionally, methods will be
Food Safety Survey measures The methods for the proposed Food employed to test for the presence of
consumers’ knowledge, attitudes, and Safety Survey will be largely the same response bias. Participation in the
beliefs about food safety. Previous as those used with the previous Food survey will be voluntary. Cognitive
versions of the survey were collected in Safety Surveys with the exception of the interviews and a pre-test will be
1988, 1993, 1998, 2001, 2006, 2010, and inclusion of address based sampling
conducted prior to fielding the survey.
2016. Food Safety Survey data are used (ABS) methods to explore the method as
to measure trends in consumer food a possible alternative for new survey In the Federal Register of July 3, 2017
safety habits including hand and cutting questions. ABS is sampling from (82 FR 30871), FDA published a 60-day
board washing, cooking practices, and address frames that are usually based, in notice requesting public comment on
use of food thermometers. Data are also part, on residential addresses in the U.S. the proposed collection of information.
used to evaluate educational messages Postal Service Computerized Delivery We received two comments. One
and to inform policymakers about Sequence File. ABS is a cost effective commenter discussed the importance of
consumer attitudes about technologies method of sampling that provides much food safety, for which FDA agrees, and
such as food irradiation and coverage of U.S. households for in- one commenter provided a comment
biotechnology. person, mail, telephone, and multimode which was unrelated to the information
The proposed Food Safety Survey will surveys (including web-based surveys.) collection. After evaluating these
contain many of the same questions and The Food Safety Survey will continue to comments, FDA will not revise the
topics as previous Food Safety Surveys include cell phones in addition to information collection.
to facilitate measuring trends in food landlines for the telephone interviews.
safety knowledge, attitudes, and A nationally representative sample of FDA estimates the burden of this
behaviors over time. The proposed 4,000 adults will be selected at random collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of Total
Number of Average burden
Activity responses per annual Total hours
respondents per response
respondent responses
Cognitive interview screener ............................... 75 1 75 0.083 (5 minutes) ........... 6
Cognitive interview .............................................. 9 1 9 1 ..................................... 9
Pretest screener .................................................. 45 1 45 0.0167 (1 minute) .......... 1
Pretest ................................................................. 18 1 18 0.33 (20 minutes) ........... 6
Survey screener .................................................. 10,000 1 10,000 0.0167 (1 minute) .......... 167
Survey ................................................................. 4,000 1 4,000 0.33 (20 minutes) ........... 1,320
Non-response survey screener ........................... 125 1 125 0.0167 (1 minute) .......... 2
Non-response survey .......................................... 50 1 50 0.167 (10 minutes) ......... 8
Total ............................................................. ........................ ........................ ........................ ........................................ 1,519
1 There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA’s burden estimate is based on the amended, notice is hereby given of the Place: National Institutes of Health, 5601
Agency’s prior experience with the following meeting. Fishers Lane, Rockville, MD 20892
Food Safety Survey. FDA estimates that (Telephone Conference Call).
The meeting will be closed to the
the burden hours for this information Contact Person: Jay R. Radke, Ph.D.,
public in accordance with the Scientific Review Officer, Scientific Review
collection will remain the same since provisions set forth in sections Program, Division of Extramural Activities,
the last OMB approval. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Room #3G11B, National Institutes of Health,
Dated: December 1, 2017. as amended. The grant applications and NIAID, 5601 Fishers Lane MSC–9823,
Leslie Kux, the discussions could disclose Bethesda, MD 20892–9823, (240) 669–5046,
Associate Commissioner for Policy. confidential trade secrets or commercial jay.radke@nih.gov.
[FR Doc. 2017–26356 Filed 12–6–17; 8:45 am]
property such as patentable material, (Catalogue of Federal Domestic Assistance
and personal information concerning Program Nos. 93.855, Allergy, Immunology,
BILLING CODE 4164–01–P
individuals associated with the grant and Transplantation Research; 93.856,
applications, the disclosure of which Microbiology and Infectious Diseases
DEPARTMENT OF HEALTH AND would constitute a clearly unwarranted Research, National Institutes of Health, HHS)
HUMAN SERVICES invasion of personal privacy. Dated: December 1, 2017.
Name of Committee: National Institute of Natasha M. Copeland,
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
Allergy and Infectious Diseases Special Program Analyst, Office of Federal Advisory
Emphasis Panel; NIAID Clinical Trial Committee Policy.
National Institute of Allergy and Implementation Cooperative Agreement
[FR Doc. 2017–26324 Filed 12–6–17; 8:45 am]
Infectious Diseases; Notice of Closed (U01).
Meeting BILLING CODE 4140–01–P
Date: January 9, 2018.
Time: 1:00 p.m. to 4:00 p.m.
Pursuant to section 10(d) of the Agenda: To review and evaluate grant
Federal Advisory Committee Act, as applications.
VerDate Sep<11>2014 18:50 Dec 06, 2017 Jkt 244001 PO 00000 Frm 00059 Fmt 4703 Sfmt 9990 E:\FR\FM\07DEN1.SGM 07DEN1](https://thefederalregister.org/doc/82_FR_57995/page/1.svg)
Document Created: 2017-12-07 00:34:39
Document Modified: 2017-12-07 00:34:39
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | January 9, 2018. | |
| FR Citation | 82 FR 57761 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR